This topic contains a solution. Click here to go to the answer

Author Question: A nonuniform linear charge distribution given by (x) = bx, where b is a constant, is distributed ... (Read 42 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
A nonuniform linear charge distribution given by (x) = bx, where b is a constant, is distributed along the x axis from x = 0 to x = +L. If b = 40 nC/m2 and L = 0.20 m, what is the electric potential (relative to a potential of zero at infinity) at the point y = 2L on the y axis?
 a. 19 V
  b. 17 V
  c. 21 V
  d. 23 V
  e. 14 V

Question 2

A linear charge of nonuniform density  = bx, where b = 2.1 nC/m2, is distributed along the x axis from x = 2.0 m to x = 3.0 m. Determine the electric potential (relative to zero at infinity) of the point y = 4.0 m on the y axis.
 a. 36 V
  b. 95 V
  c. 10 V
  d. 17 V
  e. 15 V



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

olivia_paige29

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

b

Answer to Question 2

c




Tazate

  • Member
  • Posts: 532
Reply 2 on: Jul 28, 2018
Great answer, keep it coming :)


cdmart10

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library